Lojuxta 5mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lojuxta 5mg capsules

amryt pharma - lomitapide - capsule - 5mg

Lojuxta 10mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lojuxta 10mg capsules

amryt pharma - lomitapide - capsule - 10mg

Lojuxta 20mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lojuxta 20mg capsules

amryt pharma - lomitapide - capsule - 20mg

Midazolam 1 mg/ml Solution for Injection or Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

midazolam 1 mg/ml solution for injection or infusion

accord healthcare ireland ltd. - midazolam - solution for injection/infusion - 1 milligram(s)/millilitre - benzodiazepine derivatives; midazolam

Midazolam 5 mg/ml Solution for Injection or Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

midazolam 5 mg/ml solution for injection or infusion

accord healthcare ireland ltd. - midazolam - solution for injection/infusion - 5 milligram(s)/millilitre - benzodiazepine derivatives; midazolam

Midazolam 2 mg/ml Solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

midazolam 2 mg/ml solution for injection or infusion

accord healthcare ireland ltd. - midazolam - solution for injection/infusion - 2 milligram(s)/millilitre - benzodiazepine derivatives; midazolam

LOJUXTA 10 MG Israel - English - Ministry of Health

lojuxta 10 mg

medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 10 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).

LOJUXTA 20 MG Israel - English - Ministry of Health

lojuxta 20 mg

medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 20 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).

LOJUXTA 5 MG Israel - English - Ministry of Health

lojuxta 5 mg

medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 5 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).

Miprosed 5mg/ml Oral Solution Malta - English - Medicines Authority

miprosed 5mg/ml oral solution

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - midazolam - oral solution - midazolam 5 mg/ml - psycholeptics